Try our Advanced Search for more refined results
FEDERAL TRADE COMMISSION v. ABBVIE INC et al
Case Number:
2:14-cv-05151
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
-
March 19, 2015
FTC, Abbvie Tussle Over Discovery In Pay-For-Delay Suit
The Federal Trade Commission filed a letter in Pennsylvania federal court on Wednesday saying some discovery was needed on a motion for summary judgment that was filed by AbbVie Inc., Abbott Laboratories and two others before answering the complaint or moving to dismiss in the new Androgel pay-for-delay suit.
-
September 08, 2014
FTC Targets AbbVie, Teva In 1st New Pay-For-Delay Suit
The Federal Trade Commission accused AbbVie Inc. on Monday of keeping Teva Pharmaceuticals USA Inc.'s generic AndroGel off the market through a side licensing deal, and experts say the watchdog's first pay-for-delay case since its 2013 U.S. Supreme Court win is already stretching the boundaries the justices laid out for antitrust claims under that landmark decision.
- ← Previous
- 1
- 2
- 3
- 4
- 5
- Next →